BRIEF-Forma Therapeutics Reports Qtrly Loss Per Share Of $0.68
BRIEF-Forma Therapeutics Reports Qtrly Loss Per Share Of $0.68
簡介-Forma Treeutics報告每股季度虧損0.68美元
March 30 (Reuters) - Forma Therapeutics Holdings Inc :
* FORMA THERAPEUTICS REPORTS FOURTH QUARTER AND YEAR-END 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* CURRENT CASH RUNWAY IS PROJECTED THROUGH Q3 OF 2024
* QTRLY LOSS PER SHARE $0.68
* Q4 EARNINGS PER SHARE VIEW $-0.80 -- REFINITIV IBES DATA
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
* FORMA THERAPEUTICS REPORTS FOURTH QUARTER AND YEAR-END 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* CURRENT CASH RUNWAY IS PROJECTED THROUGH Q3 OF 2024
* QTRLY LOSS PER SHARE $0.68
* Q4 EARNINGS PER SHARE VIEW $-0.80 -- REFINITIV IBES DATA
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
March 30 (Reuters) - Forma Therapeutics Holdings Inc :
* FORMA THERAPEUTICS REPORTS FOURTH QUARTER AND YEAR-END 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* CURRENT CASH RUNWAY IS PROJECTED THROUGH Q3 OF 2024
* QTRLY LOSS PER SHARE $0.68
* Q4 EARNINGS PER SHARE VIEW $-0.80 -- REFINITIV IBES DATA
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
路透3月30日電-Forma治療控股公司:*Fora Treeutics報告2020年第四季度和年末的財務業績,並提供業務最新情況*目前的現金跑道預計將持續到2024年第三季度*Qtrly每股虧損0.68美元*第四季度每股收益視圖$-0.80-REFINITIV IBES數據Eikon的源文本:進一步的公司報道:(Reurs.Briefs@thomsonreurs.com;)
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
風險及免責聲明
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
風險及免責聲明
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
搶先評論
0 0 0
讚好勁正笑哭社會社會Emm惨惨嬲嬲
輕觸選擇心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧
點擊這裡與好友分享
暫無評論,快來留言吧!